Sale!

Replica: Osimertinib Targeted EGFR Therapy for Lung Cancer

Original price was: $648.00.Current price is: $489.00.

Osimertinib, Third-generation irreversible EGFR-TKI, Treats EGFR-mutated non-small cell lung cancer, Effective against EGFR Ex19Del and EGFR L858R mutations, Central nervous system metastasis resistance,

SKU: SKU67ER9LPY5 Category:
Guaranteed Safe Checkout

Osimertinib, Third-generation irreversible EGFR-TKI, Treats EGFR-mutated non-small cell lung cancer, Effective against EGFR Ex19Del and EGFR L858R mutations, Central nervous system metastasis resistance,

Scroll to Top